Home - Centers for Medicare & Medicaid Services | CMS
We would like to show you a description here but the site won’t allow us.
This policy provides limited coverage for outpatient testing with panels using molecular syndromic panels for infectious disease pathogen identification testing.
Active MolDX LCDs - JE Part A - Noridian
Nov 3, 2025 · Print the LCD or Article: Select the LCD or Article number in the table below to view the policy or article on the Medicare Coverage Database (MCD). Click on the blue download arrow on …
LCDs & Medical Policies
Nov 5, 2025 · Provisions of the Social Security Act are applied to specific services based on various regulations, NCDs established by the CMS, various CMS guidelines, and Local Coverage …
As outlined in the policy, exceptions may be allowed in limited circumstances for bloodstream and meningoencephalitis panels testing for non-duplicative content.
This policy provides limited coverage for outpatient testing with molecular syndromic panels for infectious disease pathogen identification testing. This policy does NOT address coverage for the …
1. What tests are within scope of this policy? - Palmetto GBA
There can be various approaches for submitting syndromic test panels for consideration by MolDX. As outlined in the policy, “If additional organisms are not included in a panel, testing for those organisms …
Medicare contractors develop LCDs when there is no National Coverage Determination (NCD) or when there is a need to further define an NCD. The guidelines for LCD development are provided in …
Describe the latest MolDx reimbursement criteria and rules on molecular syndromic panels for infectious disease pathogen identification testing. Explain the implications of the new reimbursement rules on …
Frequently Asked Questions for Molecular Syndromic Panels for ...
Jul 21, 2025 · If my test is a Laboratory Developed Test (LDT) within scope of this policy, do I have to register for a DEX Z-Code® and submit for a Technical Assessment (TA) by MolDX?